https://wikem.org/w/index.php?action=history&feed=atom&title=Flecainide 2026-04-19T00:25:24Z Revision history for this page on the wiki MediaWiki 1.38.2 https://wikem.org/w/index.php?title=Flecainide&diff=229388&oldid=prev 2019-09-22T19:49:45Z

<p><span dir="auto"><span class="autocomment">References</span></span></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 19:49, 22 September 2019</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l51">Line 51:</td> <td colspan="2" class="diff-lineno">Line 51:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&lt;references/&gt;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&lt;references/&gt;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Pharmacology]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Pharmacology]]</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">[[Category:Cardiology]]</ins></div></td></tr> </table>

ClaireLewis https://wikem.org/w/index.php?title=Flecainide&diff=104734&oldid=prev 2016-10-05T09:03:10Z

<p>Created page with &quot;==Administration== *Type: Antiarrhythmic *Dosage Forms: *Routes of Administration: PO *Common Trade Names: ==Adult Dosing== *Atrial fibrillation, cardioversion (&quot;pill-in-a-...&quot;</p> <p><b>New page</b></p><div>==Administration==<br /> *Type: Antiarrhythmic <br /> *Dosage Forms:<br /> *Routes of Administration: PO<br /> *Common Trade Names: <br /> <br /> ==Adult Dosing==<br /> *Atrial fibrillation, cardioversion (&quot;pill-in-a-pocket&quot;)<br /> **200-300mg PO once<br /> *Paroxysmal atrial tachycardia (prophylaxis)<br /> **50-150mg PO BID<br /> ==Pediatric Dosing==<br /> *25-100 mg/m(2) PO 2-3 times per day, MAX dose 200 mg/m(2)/day<br /> ==Special Populations==<br /> *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C<br /> *[[Lactation risk categories|Lactation risk]]: Infant risk minimal<br /> *Renal dosing: adjustment may be required<br /> *Hepatic dosing: adjustment may be required<br /> <br /> ==Contraindications==<br /> *Allergy to class/drug<br /> *Cardiogenic shock<br /> *Right bundle branch block (without pacemaker)<br /> *2nd or 3rd degree AV block (without pacemaker)<br /> <br /> ==Adverse Reactions==<br /> ===Serious===<br /> *Heart block, sinus node dysfunction<br /> *Torsades de pointes, ventricular tachycardia, ventricular fibrillation<br /> *Cardiac shock, cardiac arrest<br /> *New onset or worsening heart failure<br /> ===Common===<br /> *Dizziness, fatigue, blurred vision<br /> *Nausea<br /> *Dyspnea<br /> <br /> ==Pharmacology==<br /> *Half-life: 12-27h<br /> *Metabolism: Hepatic, CYP2D6<br /> *Excretion: <br /> <br /> ==Mechanism of Action==<br /> *Class I C antiarrhythmic, Na+ channel blocker<br /> <br /> ==Comments==<br /> <br /> ==See Also==<br /> *[[antiarrhythmics]]<br /> <br /> ==References==<br /> &lt;references/&gt;<br /> [[Category:Pharmacology]]</div>

ClaireLewis